Experimental and Computational Fluid Dynamic study of an active ventilated façade integrating battery and distributed MPPT

Ventilated Façades integrating photovoltaic panels are a promising way to improve efficiency and the thermal-physical performances of buildings. Due the inherent intermittence of the non-programmable renewable energy sources, their increasing usage implies the use of energy storage systems to mitigate the mismatch between power generation and the buildings’ load demand. The main purpose of this paper is to investigate the thermo-fluid dynamic performances of a prototype integrating a photovoltaic cell and a battery as a module of an active ventilated façade. Based on an experimental setup, a numerical study in steady state conditions of flow through the air cavity of the module has been carried out and implemented in a fluid-dynamics Finite Volume code. In order to assess the viability of the prototype, the calibrated model was lastly used to predict thermal performance of the prototype on different climate conditions supporting its further improvement

The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study

Aims: To assess the risk of adverse neonatal outcomes in women with gestational diabetes (GDM) by identifying subgroups of women at higher risk to recognize the characteristics most associated with an excess of risk. Methods: Observational, retrospective, multicenter study involving consecutive women with GDM. To identify distinct and homogeneous subgroups of women at a higher risk, the RECursive Partitioning and AMalgamation (RECPAM) method was used. Overall, 2736 pregnancies complicated by GDM were analyzed. The main outcome measure was the occurrence of adverse neonatal outcomes in pregnancies complicated by GDM. Results: Among study participants (median age 36.8 years, pre-gestational BMI 24.8 kg/m2), six miscarriages, one neonatal death, but no maternal death was recorded. The occurrence of the cumulative adverse outcome (OR 2.48, 95% CI 1.59–3.87), large for gestational age (OR 3.99, 95% CI 2.40–6.63), fetal malformation (OR 2.66, 95% CI 1.00–7.18), and respiratory distress (OR 4.33, 95% CI 1.33–14.12) was associated with previous macrosomia. Large for gestational age was also associated with obesity (OR 1.46, 95% CI 1.00–2.15). Small for gestational age was associated with first trimester glucose levels (OR 1.96, 95% CI 1.04–3.69). Neonatal hypoglycemia was associated with overweight (OR 1.52, 95% CI 1.02–2.27) and obesity (OR 1.62, 95% CI 1.04–2.51). The RECPAM analysis identified high-risk subgroups mainly characterized by high pre-pregnancy BMI (OR 1.68, 95% CI 1.21–2.33 for obese; OR 1.38 95% CI 1.03–1.87 for overweight). Conclusions: A deep investigation on the factors associated with adverse neonatal outcomes requires a risk stratification. In particular, great attention must be paid to the prevention and treatment of obesity

An integrated building energy simulation early—Design tool for future heating and cooling demand assessment

Climate change and its effects are becoming clear on a global scale either from the perspective of global warming and the increase in the rate of occurrence of weather events of extreme magnitude. This has impacts also for sure on the standard building performance analysis approach, since the buildings designed today are supposed to withstand for the following decades climate impacts that may be different than those they were designed for. The paper proposes a simple, easy to use and freely available building simulation utility which performs morphing of existing weather data files and, by connecting to the Energy Plus simulation routine, allows to perform future climate building simulation analyses. Users are required to select one of the ASHRAE buildings models or provide one of their own choosing and to input the original weather data file. The tool will generate a future weather data file with the preferred assumptions (e.g. RCP scenarios, time frame) and elaborate results in terms of heating and cooling required for air conditioning. The paper proposes also an implementation of the tool to a case study aimed at showing the potential of the application proposed. A typical office building model from the ASHRAE library was simulated in two different locations under different climate change assumptions up to the year 2090. The analysis of the results in the two locations of Palermo (Italy) and Copenhagen (Denmark) highlight relevant increases in the current century of up to +20% of cooling requirements and similar reductions for heating in both case studies, if compared to current levels. The research targets a specific limit in the investigation of climate resilience of buildings and follows the principles described by SDSN in the definition of SDGs and the interest at the EU level towards climate neutral and innovative cities. In this context, the paper may contribute to the limited availability of easy to use and free tools available for practitioners to investigate the design of climate resilience buildings

NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future.

PurposeTo review past and current National Eye Institute (NEI)-supported age-related macular degeneration (AMD) activities and initiatives and preview upcoming coordinated efforts for studying AMD.MethodsWe conducted and summarized a portfolio analysis and literature review of NEI intramural and extramural AMD activities.ResultsThe NEI supports a broad range of AMD research, both by individual independent investigators as well as through networks and consortia. The International AMD Genomics Consortium, Age-Related Eye Disease Study, Age-Related Eye Disease Study 2 (AREDS2), and Comparison of AMD Treatments Trial legacy work probed the complex genetics, clinical presentation, and standards of patient care, respectively. The NEI AMD Pathobiology Working Group identified gaps and opportunities for future research efforts. The AMD Ryan Initiative Study and clinical trials testing the efficacies of minocycline to modulate retinal microglia activity and induced pluripotent stem cells-derived retinal pigmented epithelium (RPE) patch implants to rescue photoreceptor cell death are among the future directions for NEI-supported AMD research. Finally, NEI commissioned the creation of AREDS2 participant-derived induced pluripotent stem cell (iPSC) lines linked to their associated genomic and phenotypic datasets. These datasets will also be linked to the data obtained using their associated iPSC-derived cells (RPE, retina, choroid) and made publicly available.ConclusionsInvestments by NEI for AMD research will continue to provide invaluable resources to investigators committed to addressing this complex blinding disease and other retinal degenerative diseases.Translational relevanceNEI now stands poised to expand the resources available to clinical investigators to uncover disease mechanisms and move experimental therapies into clinical trials

Maximum likelihood identification of cavitation instabilities in axial inducers

The article illustrates the application of maximum likelihood estimation to the identification of cavitation instabilities in axial inducers from the unsteady pressure readings measured on the impeller casing. The typical triangular pressure distribution in the blade channels of the impeller is parametrized and modulated in time and space in order to theoretically reproduce the expected pressure generated by known forms of cavitation instabilities (cavitation auto-oscillations, n-lobed sub/super-synchronous rotating cavitation, higher-order surge/rotating cavitation modes). The Fourier spectra of the theoretical pressure so obtained in the rotating frame are transformed in the stationary frame and fitted by maximum likelihood estimation to the auto-correlation of the pressure measurements on the inducer casing. Each form of instability generates a characteristic spectral distribution of side bands in addition to its fundamental frequency. The identification makes use of this information for effective discrimination of simultaneous flow oscillations with significantly different intensities and partially overlapping frequencies. The method returns the estimates of the model parameters and their standard errors, allowing for both recognition of the forms of instabilities occurring in the inducer and assessment of the statistical significance of the results

Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update

Andrea Tumminia,1 Laura Sciacca,1 Lucia Frittitta,1 Sebastiano Squatrito,1 Riccardo Vigneri,2 Rosario Le Moli,1 Letizia Tomaselli2 1Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Hospital, Catania, Italy; 2Endocrinology, Garibaldi-Nesima Hospital, Catania, Italy Abstract: Insulin pump therapy combined with real-time continuous glucose monitoring, known as sensor-augmented pump (SAP) therapy, has been shown to improve metabolic control and to reduce the rate of hypoglycemia in adults with type 1 diabetes compared to multiple daily injections or standard continuous subcutaneous insulin infusion. Glycemic variability is also reduced in patients on SAP therapy. This approach allows patients to monitor their glucose levels being informed of glycemic concentration and trend. Trained diabetic patients, therefore, can appropriately modify insulin infusion and/or carbohydrate intake in order to prevent hypo- or hyperglycemia. For these reasons, SAP therapy is now considered the gold standard for type 1 diabetes treatment. To be clinically effective, however, devices and techniques using advanced technology should not only have the potential to theoretically ameliorate metabolic control, but also be well accepted by patients in terms of satisfaction and health-related quality of life, because these factors will improve treatment adherence and consequently overall outcome. SAP therapy is generally well tolerated by patients; however, many clinical trials have identified significant noncompliance in the use of this device, most notably in the pediatric and adolescent populations. In this review we aim to analyze the main reasons for good or poor adherence to SAP therapy and to provide useful tips in order to fully benefit from this kind of novel therapeutic approach. Keywords: sensor-augmented insulin pump therapy, type 1 diabetes, quality of life, patient adherence, continuous subcutaneous insulin infusio

NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future.

PurposeTo review past and current National Eye Institute (NEI)-supported age-related macular degeneration (AMD) activities and initiatives and preview upcoming coordinated efforts for studying AMD.MethodsWe conducted and summarized a portfolio analysis and literature review of NEI intramural and extramural AMD activities.ResultsThe NEI supports a broad range of AMD research, both by individual independent investigators as well as through networks and consortia. The International AMD Genomics Consortium, Age-Related Eye Disease Study, Age-Related Eye Disease Study 2 (AREDS2), and Comparison of AMD Treatments Trial legacy work probed the complex genetics, clinical presentation, and standards of patient care, respectively. The NEI AMD Pathobiology Working Group identified gaps and opportunities for future research efforts. The AMD Ryan Initiative Study and clinical trials testing the efficacies of minocycline to modulate retinal microglia activity and induced pluripotent stem cells-derived retinal pigmented epithelium (RPE) patch implants to rescue photoreceptor cell death are among the future directions for NEI-supported AMD research. Finally, NEI commissioned the creation of AREDS2 participant-derived induced pluripotent stem cell (iPSC) lines linked to their associated genomic and phenotypic datasets. These datasets will also be linked to the data obtained using their associated iPSC-derived cells (RPE, retina, choroid) and made publicly available.ConclusionsInvestments by NEI for AMD research will continue to provide invaluable resources to investigators committed to addressing this complex blinding disease and other retinal degenerative diseases.Translational relevanceNEI now stands poised to expand the resources available to clinical investigators to uncover disease mechanisms and move experimental therapies into clinical trials